Azenta Inc (AZTA)
52.10
-0.36
(-0.69%)
USD |
NASDAQ |
May 01, 16:00
52.14
+0.04
(+0.08%)
After-Hours: 20:00
Azenta Free Cash Flow: 32.43M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.43M |
| September 30, 2023 | -21.95M |
| June 30, 2023 | -55.71M |
| March 31, 2023 | -500.29M |
| December 31, 2022 | -580.55M |
| September 30, 2022 | -543.48M |
| June 30, 2022 | -530.50M |
| March 31, 2022 | -59.42M |
| December 31, 2021 | 65.76M |
| September 30, 2021 | 97.05M |
| June 30, 2021 | 129.70M |
| March 31, 2021 | 111.58M |
| December 31, 2020 | 10.32M |
| September 30, 2020 | -2.058M |
| June 30, 2020 | -19.27M |
| March 31, 2020 | -6.743M |
| December 31, 2019 | 80.46M |
| September 30, 2019 | 67.04M |
| June 30, 2019 | 70.43M |
| March 31, 2019 | 55.98M |
| December 31, 2018 | 63.36M |
| September 30, 2018 | 61.18M |
| June 30, 2018 | 62.19M |
| March 31, 2018 | 62.91M |
| December 31, 2017 | 68.88M |
| Date | Value |
|---|---|
| September 30, 2017 | 83.31M |
| June 30, 2017 | 74.56M |
| March 31, 2017 | 70.56M |
| December 31, 2016 | 56.50M |
| September 30, 2016 | 26.70M |
| June 30, 2016 | 18.75M |
| March 31, 2016 | 20.56M |
| December 31, 2015 | 11.26M |
| September 30, 2015 | 27.58M |
| June 30, 2015 | 26.84M |
| March 31, 2015 | 16.61M |
| December 31, 2014 | 42.26M |
| September 30, 2014 | 48.26M |
| June 30, 2014 | 60.78M |
| March 31, 2014 | 68.54M |
| December 31, 2013 | 53.74M |
| September 30, 2013 | 50.75M |
| June 30, 2013 | 28.10M |
| March 31, 2013 | 25.24M |
| December 31, 2012 | 28.81M |
| September 30, 2012 | 27.38M |
| June 30, 2012 | 44.35M |
| March 31, 2012 | 62.76M |
| December 31, 2011 | 68.20M |
| September 30, 2011 | 81.20M |
Free Cash Flow Range, Past 5 Years
-580.55M
Minimum
Dec 2022
129.70M
Maximum
Jun 2021
-87.12M
Average
-2.058M
Median
Sep 2020
Free Cash Flow Benchmarks
| Bruker Corp | 243.20M |
| Harvard Bioscience Inc | 11.72M |
| Bionano Genomics Inc | -126.87M |
| Akoya Biosciences Inc | -54.55M |
| Singular Genomics Systems Inc | -74.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 26.43M |
| Cash from Investing (Quarterly) | 98.40M |
| Cash from Financing (Quarterly) | -113.15M |
| Free Cash Flow Per Share (Quarterly) | 0.2559 |
| Free Cash Flow to Equity (Quarterly) | 14.51M |
| Free Cash Flow to Firm (Quarterly) | 14.51M |
| Free Cash Flow Yield | 1.00% |